COVID-19住院患者接受产生气溶胶操作时的SARS-CoV-2环境污染
该前瞻性观察性环境采样研究纳入30例需 supplemental oxygen 的COVID-19住院患者,每组10例分别接受普通补氧、CPAP或HFNO,采集鼻咽拭子及空气和表面样本进行RT-qPCR和培养。结果显示仅4/90空气和6/90表面样本病毒RNA阳性,CPAP/HFNO或咳嗽未显著增加环境污染,仅1份鼻咽样本培养阳性。
要点
- CPAP/HFNO治疗中/重症COVID-19未显著增加即时诊疗环境的空气或表面病毒污染。
- 30例患者中21例鼻咽拭子SARS-CoV-2 RNA阳性,但空气和表面样本阳性率低。
- 仅1份鼻咽样本培养出活病毒,环境样本未分离到活病毒。
核心结论
- 与普通补氧相比,使用CPAP或HFNO治疗中/重症COVID-19似乎并未导致即时诊疗环境的空气或表面病毒污染水平显著升高。
研究设计与样本
- 前瞻性观察性环境采样研究,纳入30例需 supplemental oxygen 且FiO2≥0.4以维持SpO2≥94%的COVID-19住院患者,每组10例分别接受普通补氧、CPAP或HFNO。
主要发现
- 21/30(70%)患者鼻咽拭子SARS-CoV-2 RNA阳性。
- 空气样本中4/90(4%)病毒RNA阳性,表面样本中6/90(7%)阳性,空气和表面各有额外10份疑似阳性样本。
- CPAP/HFNO使用或咳嗽与普通补氧相比未显著增加环境污染。
- 仅1份鼻咽样本培养阳性。
临床怎么用
- 在即时诊疗环境中,CPAP和HFNO使用未显示显著增加空气或表面病毒污染,可参考此结果评估医务人员暴露风险。
局限性
- 样本量较小(每组10例),环境采样为观察性设计,可能影响结果的外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Continuous positive airways pressure (CPAP) and high-flow nasal oxygen (HFNO) are considered 'aerosol-generating procedures' in the treatment of COVID-19. OBJECTIVE: To measure air and surface environmental contamination with SARS-CoV-2 virus when CPAP and HFNO are used, compared with supplemental oxygen, to investigate the potential risks of viral transmission to healthcare workers and patients. METHODS: 30 hospitalised patients with COVID-19 requiring supplemental oxygen, with a fraction of inspired oxygen ≥0.4 to maintain oxygen saturation ≥94%, were prospectively enrolled into an observational environmental sampling study. Participants received either supplemental oxygen, CPAP or HFNO (n=10 in each group). A nasopharyngeal swab, three air and three surface samples were collected from each participant and the clinical environment. Real-time quantitative polymerase chain reaction analyses were performed for viral and human RNA, and positive/suspected-positive samples were cultured for the presence of biologically viable virus. RESULTS: Overall 21/30 (70%) participants tested positive for SARS-CoV-2 RNA in the nasopharynx. In contrast, only 4/90 (4%) and 6/90 (7%) of all air and surface samples tested positive (positive for E and ORF1a) for viral RNA respectively, although there were an additional 10 suspected-positive samples in both air and surfaces samples (positive for E or ORF1a). CPAP/HFNO use or coughing was not associated with significantly more environmental contamination than supplemental oxygen use. Only one nasopharyngeal sample was culture positive. CONCLUSIONS: The use of CPAP and HFNO to treat moderate/severe COVID-19 did not appear to be associated with substantially higher levels of air or surface viral contamination in the immediate care environment, compared with the use of supplemental oxygen.
引用
- Winslow RL, Zhou J, Windle EF, et al. SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures. Thorax. 2021. PMID: 34737194. doi:10.1136/thoraxjnl-2021-218035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。